ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

VTVT vTv Therapeutics Inc

23.63
-0.0699 (-0.29%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
vTv Therapeutics Inc VTVT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0699 -0.29% 23.63 13:00:09
개장가 저가 고가 종가 전일 종가
22.85 22.5001 24.33 23.63 23.6999
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
19/03/202421:30PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA..
13/03/202421:00GLOBEvTv Therapeutics Announces 2023 Fourth Quarter and Full Year..
08/03/202406:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/03/202409:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
05/03/202422:04EDGAR2Form 8-K - Current report
04/03/202422:00GLOBEvTv Therapeutics Announces FDA Submission for First Phase 3..
01/03/202422:00GLOBEvTv Therapeutics to Participate at the TD Cowen 44th Annual..
28/02/202423:26EDGAR2Form 8-K - Current report
28/02/202423:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/02/202422:08EDGAR2Form 8-K - Current report
28/02/202422:00GLOBEvTv Therapeutics Announces $51 Million Private Placement..
23/02/202406:00PRNUSCANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO &..
23/12/202306:26EDGAR2Form 8-K - Current report
20/12/202306:28EDGAR2Form 8-K - Current report
13/12/202306:21EDGAR2Form 8-K - Current report
21/11/202306:23EDGAR2Form 8-K - Current report
15/11/202322:22EDGAR2Form 8-K - Current report
15/11/202322:19EDGAR2Form 8-K - Current report
10/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:30GLOBEvTv Therapeutics Announces 2023 Third Quarter Financial..
10/11/202306:20EDGAR2Form 8-K - Current report
08/11/202322:00GLOBEvTv Therapeutics to Participate at the Stifel 2023..
02/11/202321:00GLOBEvTv Therapeutics Appoints Thomas Strack, M.D., as Chief..
01/11/202321:24EDGAR2Form 8-K - Current report
01/11/202321:00GLOBEvTv Therapeutics Announces Sale of Shares in Reneo..
27/09/202321:30PRNUSCANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A..
26/09/202321:30PRNUSCantex and Allegheny Health Network Announce Initiation of a..
26/09/202305:20EDGAR2Form DEF 14C - Other definitive information statements
18/09/202321:30PRNUSCANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE..
16/09/202305:17EDGAR2Form PRE 14C - Other preliminary information statements
12/08/202305:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/08/202305:36EDGAR2Form 8-K - Current report
12/08/202305:30GLOBEvTv Therapeutics Announces 2023 Second Quarter Financial..
10/08/202321:33PRNUSCantex Pharmaceuticals Announces Article Published in npj..
21/07/202305:22EDGAR2Form 8-K - Current report
16/06/202321:00GLOBEvTv Therapeutics Partner Cantex Pharmaceuticals Licenses..
15/06/202320:33PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY..
24/05/202322:00GLOBEvTv Therapeutics Announces Issuance of U.S. Patent for..
12/05/202305:15GLOBEvTv Therapeutics Announces 2023 First Quarter Financial..

최근 히스토리

Delayed Upgrade Clock